385 related articles for article (PubMed ID: 16314086)
1. Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies.
de Bock GH; van der Hage JA; Putter H; Bonnema J; Bartelink H; van de Velde CJ
Eur J Cancer; 2006 Feb; 42(3):351-6. PubMed ID: 16314086
[TBL] [Abstract][Full Text] [Related]
2. Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials.
Nielsen HM; Overgaard M; Grau C; Jensen AR; Overgaard J
Radiother Oncol; 2006 May; 79(2):147-55. PubMed ID: 16647152
[TBL] [Abstract][Full Text] [Related]
3. Using loco-regional recurrence as an indicator of the quality of breast cancer treatment.
Ernst MF; Voogd AC; Coebergh JW; Poortmans PM; Roukema JA
Eur J Cancer; 2004 Mar; 40(4):487-93. PubMed ID: 14962713
[TBL] [Abstract][Full Text] [Related]
4. Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first.
Bollet MA; Sigal-Zafrani B; Mazeau V; Savignoni A; de la Rochefordière A; Vincent-Salomon A; Salmon R; Campana F; Kirova YM; Dendale R; Fourquet A
Radiother Oncol; 2007 Mar; 82(3):272-80. PubMed ID: 17287037
[TBL] [Abstract][Full Text] [Related]
5. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
Fodor J
Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
[TBL] [Abstract][Full Text] [Related]
6. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
; ; Bijker N; Meijnen P; Peterse JL; Bogaerts J; Van Hoorebeeck I; Julien JP; Gennaro M; Rouanet P; Avril A; Fentiman IS; Bartelink H; Rutgers EJ
J Clin Oncol; 2006 Jul; 24(21):3381-7. PubMed ID: 16801628
[TBL] [Abstract][Full Text] [Related]
7. Survival and breast relapse in 3834 patients with T1-T2 breast cancer after conserving surgery and adjuvant treatment.
Livi L; Paiar F; Saieva C; Scoccianti S; Dicosmo D; Borghesi S; Agresti B; Nosi F; Orzalesi L; Santini R; Barca R; Biti GP
Radiother Oncol; 2007 Mar; 82(3):287-93. PubMed ID: 17188382
[TBL] [Abstract][Full Text] [Related]
8. Breast conserving treatment in Denmark, 1989-1998. A nationwide population-based study of the Danish Breast Cancer Co-operative Group.
Ewertz M; Kempel MM; Düring M; Jensen MB; Andersson M; Christiansen P; Kroman N; Rasmussen BB; Overgaard M
Acta Oncol; 2008; 47(4):682-90. PubMed ID: 18465336
[TBL] [Abstract][Full Text] [Related]
9. The impact of loco-regional recurrences on metastatic progression in early-stage breast cancer: a multistate model.
de Bock GH; Putter H; Bonnema J; van der Hage JA; Bartelink H; van de Velde CJ
Breast Cancer Res Treat; 2009 Sep; 117(2):401-8. PubMed ID: 19148746
[TBL] [Abstract][Full Text] [Related]
10. Breast conservation surgery achieving>or=2 mm tumor-free margins results in decreased local-regional recurrence rates.
Kunos C; Latson L; Overmoyer B; Silverman P; Shenk R; Kinsella T; Lyons J
Breast J; 2006; 12(1):28-36. PubMed ID: 16409584
[TBL] [Abstract][Full Text] [Related]
11. The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: How young is "young"?
Oh JL; Bonnen M; Outlaw ED; Schechter NR; Perkins GH; Strom EA; Babiera G; Oswald MJ; Allen PK; Thames HD; Buchholz TA
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1345-52. PubMed ID: 16750315
[TBL] [Abstract][Full Text] [Related]
12. Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer.
Galper S; Blood E; Gelman R; Abner A; Recht A; Kohli A; Wong JS; Smith D; Bellon J; Connolly J; Schnitt S; Winer E; Silver B; Harris JR
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):348-57. PubMed ID: 15667952
[TBL] [Abstract][Full Text] [Related]
13. Regional nodal recurrence after breast conservation treatment with radiotherapy for women with early-stage breast carcinoma.
Lukens JN; Vapiwala N; Hwang WT; Solin LJ
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1475-81. PubMed ID: 19004570
[TBL] [Abstract][Full Text] [Related]
14. The safety of breast-conserving therapy in patients with breast cancer aged < or = 40 years.
van der Leest M; Evers L; van der Sangen MJ; Poortmans PM; van de Poll-Franse LV; Vulto AJ; Nieuwenhuijzen GA; Brenninkmeijer SJ; Creemers GJ; Voogd AC
Cancer; 2007 May; 109(10):1957-64. PubMed ID: 17394192
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome of breast conservation therapy for breast cancer in Hong Kong: prognostic impact of ipsilateral breast tumor recurrence and 2005 St. Gallen risk categories.
Yau TK; Soong IS; Chan K; Chan M; Cheung P; Lau HW; Chang AT; Lee AW
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):667-72. PubMed ID: 17379441
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of breast-conserving therapy for breast cancer.
Shimauchi A; Nemoto K; Ogawa Y; Kakuto Y; Sakayauchi T; Takai Y; Ishida T; Ohuchi N; Hirakawa H; Kimura M; Yamada T; Takahashi S; Yamada S
Radiat Med; 2005 Nov; 23(7):485-90. PubMed ID: 16485539
[TBL] [Abstract][Full Text] [Related]
17. Prognosis following local recurrence after breast conserving treatment in young women with early breast cancer.
van der Sangen MJ; Poortmans PM; Scheepers SW; Lemaire BM; van Berlo CL; Tjan-Heijnen VC; Voogd AC
Eur J Surg Oncol; 2013 Aug; 39(8):892-8. PubMed ID: 23726902
[TBL] [Abstract][Full Text] [Related]
18. Profile of prognostic factors in 1022 Indian women with early-stage breast cancer treated with breast-conserving therapy.
Dinshaw KA; Budrukkar AN; Chinoy RF; Sarin R; Badwe R; Hawaldar R; Shrivastava SK
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1132-41. PubMed ID: 15978744
[TBL] [Abstract][Full Text] [Related]
19. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
[TBL] [Abstract][Full Text] [Related]
20. Tumor location, interval between surgery and radiotherapy, and boost technique influence local control after breast-conserving surgery and radiation: retrospective analysis of monoinstitutional long-term results.
Knauerhase H; Strietzel M; Gerber B; Reimer T; Fietkau R
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1048-55. PubMed ID: 18359170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
